Seeking Alpha

  Arrowhead Research Corporation (ARWR) - NASDAQ

  • Jim Van Meerten | Send Message 7 Nov 2011

    ARWR - 80% Barchart technical buy signal - 18 new highs and up 53.85% in the last month - Relative strngth Index 70.73% and rising
    Reply
      ARWR vs. ETF Alternatives
      Company Description
      Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States